Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35bce0b8363dc3e87c11597734a15083 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
filingDate |
2014-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dbbacc9851e35aaa9d89e46db743e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1e28063904d8ec8f725743c6c74d72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2588fe5c79c2d4ea44cb44b0fa9487d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d4ce37cbf0fe19b8dea6975eea4b89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b67c08bad1fd1232253a865db1209f7 |
publicationDate |
2015-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014167436-A3 |
titleOfInvention |
Sunitinib glucuronate salt & process for preparation thereof |
abstract |
The present invention relates to novel pharmaceutically acceptable glucuronic acid addition salt of Sunitinib Formula (I) or its solvate thereof. The present invention further relates to the processes for preparation of the glucuronic acid addition salt of Sunitinib. Glucuronic acid addition salt of Sunitinib (I) prepared according to the process of the present invention is obtained as a solid material. The pharmaceutical compositions comprising glucuronic acid addition salt of Sunitinib or its solvate thereof may be useful as anti-cancer agent. |
priorityDate |
2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |